Colorado Springs, COLORADO1 Active Studies

Celiac Disease Clinical Trials in Colorado Springs, COLORADO

Find 1 actively recruiting celiac disease clinical trials in Colorado Springs, COLORADO. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
48
Enrolling

Recruiting Celiac Disease Studies in Colorado Springs

About Celiac Disease Clinical Trials in Colorado Springs

Celiac disease is an autoimmune condition triggered by eating gluten, causing damage to the small intestine lining. It affects about 1% of the global population and can cause digestive symptoms, malnutrition, and other complications. The primary treatment is a strict lifelong gluten-free diet.

There are currently 1 celiac disease clinical trials recruiting participants in Colorado Springs, COLORADO. These studies are seeking a combined 48 participants. Research is being sponsored by Teva Branded Pharmaceutical Products R&D LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Celiac Disease Clinical Trials in Colorado Springs — FAQ

Are there celiac disease clinical trials in Colorado Springs?

Yes, there are 1 celiac disease clinical trials currently recruiting in Colorado Springs, COLORADO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What celiac disease treatments are being tested?

The 1 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for celiac disease.

Data updated March 2, 2026 from ClinicalTrials.gov